Activation of Rho GTPases in Smith-Lemli-Opitz syndrome: pathophysiological and clinical implications.
about
An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndromeNanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndromeRho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiencyThe role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: A hypothesis paperDesmosterol in brain is elevated because DHCR24 needs REST for Robust Expression but REST is poorly expressed.Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylationMalformation syndromes caused by disorders of cholesterol synthesis.Negative regulation of RhoA translation and signaling by hnRNP-Q1 affects cellular morphogenesis.Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.Review: Transport of maternal cholesterol to the fetal circulation.Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypesDHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome modelBrain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.The Type VI secretion system of Burkholderia cenocepacia affects multiple Rho family GTPases disrupting the actin cytoskeleton and the assembly of NADPH oxidase complex in macrophages.Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome.Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients.Thapsigargin induces apoptosis by impairing cytoskeleton dynamics in human lung adenocarcinoma cells.
P2860
Q24597916-87A87351-7C3E-4962-ACEF-B4617AB59593Q24633389-8973E817-F9C0-44BA-ACE7-248C0F148072Q28274176-C81A0C58-10AC-494F-9831-94B9AA79CBEAQ33543669-2D5452D3-28D7-42D7-B992-403CF88A9509Q33835785-28C42803-DFF9-4105-BDE4-BEE05C415B69Q33933603-D1894069-228C-49FD-AA07-A1CAF5228D67Q34249114-09705BD8-9431-4BE2-8B44-8C3B2ACD689FQ34395171-D07AA5A6-383D-42FA-AA29-B9EFFF9D2CA7Q35891195-D21F9052-7127-4A57-BA0D-659BD73523DEQ36353769-BFEA5094-E6F8-4261-80EE-1D8F4DA93B61Q36425855-C737561E-845F-4946-9A02-AF491C2F871DQ36772356-7619C89F-1709-4540-BAA6-650378527C2CQ36908135-C73D8F9C-2931-442A-97F3-833A28E4A765Q38813613-CE3129B9-0F53-4E1C-85EA-7F5F49386012Q39453649-D25AE53B-2665-4267-BE79-BF7B1DDAD269Q52740668-CC617159-1DCE-49EA-8D2D-7EFB1FCEB3DFQ54858134-CF6655D7-F0ED-4B40-AA47-B08F5AA89FE6Q55652515-BEE02780-5F2E-4045-9E03-CAD40E8B0CAF
P2860
Activation of Rho GTPases in Smith-Lemli-Opitz syndrome: pathophysiological and clinical implications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of Rho GTPases in S ...... cal and clinical implications.
@ast
Activation of Rho GTPases in S ...... cal and clinical implications.
@en
type
label
Activation of Rho GTPases in S ...... cal and clinical implications.
@ast
Activation of Rho GTPases in S ...... cal and clinical implications.
@en
prefLabel
Activation of Rho GTPases in S ...... cal and clinical implications.
@ast
Activation of Rho GTPases in S ...... cal and clinical implications.
@en
P2093
P2860
P356
P1476
Activation of Rho GTPases in S ...... cal and clinical implications.
@en
P2093
Alfred L Yergey
Christopher A Wassif
Forbes D Porter
Lynne A Holtzclaw
Peter S Backlund
Xiao-Sheng Jiang
P2860
P304
P356
10.1093/HMG/DDQ011
P577
2010-01-12T00:00:00Z